Status:
TERMINATED
PET-CT Scans in Healthy Volunteers After Flu Vaccination
Lead Sponsor:
Hackensack Meridian Health
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Flu
Eligibility:
All Genders
21-55 years
Phase:
NA
Brief Summary
This study is being done to learn how previous flu vaccination or previous infection with flu virus affects the immune response to vaccination.
Detailed Description
Until recently, all recipients of influenza vaccine received a killed form of virus, typically in the same nondominant arm, each year before flu season. We hypothesize that natural infection, and some...
Eligibility Criteria
Inclusion
- Men and women 21-55 years old.
- Willingness to participate in the study for a full year including multiple blood draws and PET-CT scanning
Exclusion
- Diabetes
- Use of systemic steroids
- Pregnancy or unwillingness to practice birth control of some kind through the PET-CT scanning period
- Recent vaccination for other reasons (e.g., traveler's vaccines)
- Significant intercurrent illness that might interfere with vaccination "take" or interpretation of PET-CT scanning (e.g., chemotherapy for cancer)
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00769002
Start Date
September 1 2008
End Date
August 1 2011
Last Update
October 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hackensack Univarsity medical Center
Hackensack, New Jersey, United States, 07601